US Physical Therapy Inc (USPH)

From the record

US Physical Therapy Inc's filings since 2017 show 5 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, the latest 2017-04-07); a warning not to rely on past financial statements (8-K item 4.02, the latest 2017-03-16); a late-report notice (Form NT 10-K or NT 10-Q, 3 times, the latest 2024-08-09) (its current reports).

From the record

US Physical Therapy Inc's 10 filed years say what it did: revenue went from $357 million in fiscal 2016 to $781 million in fiscal 2025, up 9.1% a year; it rose in 8 of 9 years; the deepest fall was 12% from fiscal 2019 to fiscal 2020; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, US Physical Therapy Inc's diluted share count grew about 5.3% a year, and dividends and buybacks returned about 36% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 5 sales and 5 purchases of their own stock on the open market in the year to 2026-10-02, buying about $325 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, US Physical Therapy Inc earned about 8 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 12 cents per dollar of everything the company owns. Leverage: it owed about 60 cents per dollar of assets, and net share issuance: its share count grew 0.7% over the year (the filed statements).

From the record

US Physical Therapy Inc's standing among 14 graded names in its industry family: revenue of $781 million in fiscal 2025 ranks in the top 39% by size; a net margin of 5.1% ranks in the top 11%; revenue growth of 12.2% a year over the last 3 filed years ranks in the bottom 32% (its annual reports).

From the record

US Physical Therapy Inc's leadership, from its insiders' filings and its current reports: the chief executive on the record is Reading, Christopher J (Chairman of the Board and CEO, as filed), filing under that title since 2006-05-10, 20.5 years (top 5% of its family); the 14 officers and directors filing in the last fifteen months have been on the record a median of 5.1 years (top 32%); 10 officer or director changes were reported on Form 8-K since 2023-11-13, against the 14 people in charge now (bottom 4%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

US Physical Therapy Inc's room to grow, from the newest filed statements (fiscal 2025): cash of $36 million against debt of $153 million leaves -9.7% of its assets as net cash, bottom 18% of its family; cash from operations less capital spending is 7.8% of revenue (top 11%); a gross margin of 19.2% (bottom 6%) (its annual report).

From the record

US Physical Therapy Inc's growth drivers, from the filed years to fiscal 2025: revenue grew 12.2% a year over the last three filed years against 9.1% over all 10, speeding up (top 32% of its family); the newest year grew 16.3% (bottom 39%); capital spending grew 19.5% a year (top 42%) (its annual reports). US Physical Therapy Inc reported 3 product lines in fiscal 2025: Net Patient Revenues at $650 million (82%), Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues at $131 million (17%), Management Contract Revenues at $10 million (1%); 2 of 3 grew against the year before (its annual report).

From the record

US Physical Therapy Inc's newest year against its own record: revenue of $781 million in fiscal 2025 came in 5.6% above the $740 million its prior three years' pace pointed to (bottom 46% of its family); net income of $40 million against a prior three-year average of $31 million (bottom 29%); a net margin of 5.1% against 5.1% before (bottom 21%) (its annual reports).